t.me/Abdusalim_Shavkatov page 12 when researchers noticed that they were always separated from one another by
equally odd 'spacer' gene sequences.
4. Then, a little over a decade ago, scientists made an important discovery. Those
'spacer' sequences look odd because they aren't bacterial in origin. Many are actually
snippets of DNA from viruses that are known to attack bacteria. In 2005, three
research groups independently reached the same conclusion: CRISPR and its
associated genetic sequences were acting as a bacterial immune system. In simple
terms, this is how it works. A bacterial cell generates special proteins from genes
associated with the CRISPR repeats (these are called CRISPR associated - Cas -
proteins). If a virus invades the cell, these Cas proteins bind to the viral DNA and help
cut out a chunk. Then, that chunk of viral DNA gets carried back to the bacterial cell's
genome where it is inserted - becoming a spacer. From now on, the bacterial cell can
use the spacer to recognise that particular virus and attack it more effectively.
5. These findings were a revelation. Geneticists quickly realised that the CRISPR system
effectively involves microbes deliberately editing their own genomes - suggesting the
system could form the basis of a brand new type of genetic engineering technology.
They worked out the mechanics of the CRISPR system and got it working in their lab
experiments. It was a breakthrough that paved the way for this week's
announcement by the HFEA. Exactly who took the key steps to turn CRISPR into a
useful genetic tool is, however, the subject of a huge controversy. Perhaps that's
inevitable - credit for developing CRISPR gene editing will probably guarantee both
scientific fame and financial wealth.
6. Beyond these very important practical applications, though, there's another CRISPR
story. It's the account of how the discovery of CRISPR has influenced evolutionary
biology. Sometimes overlooked is the fact that it wasn't just geneticists who were
excited by CRISPR's discovery - so too were biologists. They realised CRISPR was
evidence of a completely unexpected parallel between the way humans and bacteria
fight infections. We've known for a long time that part of our immune system
"learns" about the pathogens it has seen before so it can adapt and fight infections
better in future. Vertebrate animals were thought to be the only organisms with such
a sophisticated adaptive immune system. In light of the discovery of CRISPR, it
seemed some bacteria had their own version. In fact, it turned out that lots of
bacteria have their own version. At the last count, the CRISPR adaptive immune
system was estimated to be present in about 40% of bacteria. Among the other
major group of single-celled microbes - the archaea - CRISPR is even more common.
It's seen in about 90% of them. If it's that common today, CRISPR must have a history
stretching back over millions - possibly even billions - of years. "It's clearly been
around for a while," says Darren Griffin at the University of Kent.